Executive Director Message - July/August 2022
Increasingly, our patients tell us they have been referred by their physician to have proton therapy. This is a good sign. It tells us that our colleagues in medicine see the evidence and the value of protons to treat many types of cancers effectively.
Prostate Cancer Study:
Proton therapy achieves high efficacy with a shorter course of treatment. Typically, proton therapy for prostate cancer is given over an eight-week period with 39 treatments. There is new evidence from the UF Health Proton Therapy Institute that a six-week, 28-treatment course of proton therapy is highly effective and achieves excellent prostate cancer patient outcomes.
Patient Spotlight: Abe DeLeon aka Proton Man
You may have seen a man outfitted as Proton Man in the halls at the UF Health Proton Therapy Institute this summer. Under the mask and cape: Abe DeLeon from Roswell, Georgia, who was being treated for prostate cancer.
In our first 15 years we have made medical history as the first to offer proton therapy in the state of Florida and all of the Southeastern United States. We have treated more than 10,000 patients and opened over 65 clinical trials.
Annual Proton Ambassador Program Update
Are you a UF Health Proton Therapy Institute Ambassador? If so, be sure to join us live online via Zoom for an Ambassador meeting on Tuesday, August 16 at 12 p.m.
Dr. Adam Holtzman Appointed Deputy Operations Editor of the International Journal of Particle Therapy
Adam L. Holtzman, MD, Assistant Professor in the Department of Radiation Oncology, Jacksonville, was appointed Deputy Operations Editor of the International Journal of Particle Therapy (IJPT) on March 1, 2022.
Welcome Kasey Heilman, Director of Development
Welcome Kasey Heilman, Director of Development The UF Health Proton Therapy Institute has appointed Kasey Heilman as Director of Development. In her new role, Kasey will lead the development and implementation of fundraising programs to support and advance the priorities of the Institute. She works closely with donors, volunteers, patients, faculty and staff to advance philanthropic initiatives.